WS
ENTX icon

Wedbush Securities’s Entera Bio ENTX Stock Holding History

Wedbush Securities’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-121,616
Closed -$151K – 903
2020
Q3 		$151K Buy
121,616
+91,608
+305% +$139K 0.01% 791
2020
Q2 		$55K Buy
+30,008
New +$61.2K 0.01% 898

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wedbush Securities's ENTX Position: Q4 2020 in Review

Wedbush Securities sold out of Entera Bio (ENTX) in Q4 2020, closing a stake of 121,616 shares — an estimated $151K sold.

Wedbush Securities first reported a position in ENTX in Q2 2020 and held it in 2 quarters. The position peaked at $151K in Q3 2020. 5 funds tracked by Wall St. Rank hold ENTX as of Q4 2020.

  • Wedbush Securities reported no remaining Entera Bio position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 121,616 Entera Bio shares in Q4 2020, an estimated $151K.
  • Wedbush Securities first reported a position in Entera Bio in Q2 2020 and held it in 2 quarters.
  • Wedbush Securities's Entera Bio position peaked at $151K in Q3 2020.
  • 5 funds tracked by Wall St. Rank held Entera Bio as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.